Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73


Resizing the genomic regulation of restenosis.

Matsumoto T, Hwang PM.

Circ Res. 2007 Jun 8;100(11):1537-9. No abstract available.


MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation.

Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, Dean DB, Zhang C.

Circ Res. 2007 Jun 8;100(11):1579-88. Epub 2007 May 3.


Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides.

Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI.

J Clin Invest. 1994 Feb;93(2):820-8.


Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action.

Bennett MR, Lindner V, DeBlois D, Reidy MA, Schwartz SM.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2326-32.


Effects of antisense c-myb oligonucleotides on vascular smooth muscle cell proliferation and response to vessel wall injury.

Villa AE, Guzman LA, Poptic EJ, Labhasetwar V, D'Souza S, Farrell CL, Plow EF, Levy RJ, DiCorleto PE, Topol EJ.

Circ Res. 1995 Apr;76(4):505-13.


Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease.

Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH.

Nat Med. 1998 Feb;4(2):222-7.


Localization of c-Myb and induction of apoptosis by antisense oligonucleotide c-Myb after angioplasty of porcine coronary arteries.

Lambert DL, Malik N, Shepherd L, Gunn J, Francis SE, King A, Crossman DC, Cumberland DC, Holt CM.

Arterioscler Thromb Vasc Biol. 2001 Nov;21(11):1727-32.


c-Myc antisense oligonucleotides preserve smooth muscle differentiation and reduce negative remodelling following rat carotid arteriotomy.

Forte A, Galderisi U, De Feo M, Gomez MF, Esposito S, Santè P, Renzulli A, Agozzino L, Hellstrand P, Berrino L, Cipollaro M, Cotrufo M, Rossi F, Cascino A.

J Vasc Res. 2005 May-Jun;42(3):214-25. Epub 2005 Apr 20.


Perspectives on antisense therapy for the prevention of restenosis.

Kipshidze N, Moses J, Shankar LR, Leon M.

Curr Opin Mol Ther. 2001 Jun;3(3):265-77. Review.


[Antisense oligonucleotides inhibit c-myc and PCNA expression in the vascular smooth muscle cells].

Bian J, Zhang B, Chen S.

Zhonghua Yi Xue Za Zhi. 1999 Jan;79(1):10-4. Chinese.


Fibrillar collagen specifically regulates human vascular smooth muscle cell genes involved in cellular responses and the pericellular matrix environment.

Ichii T, Koyama H, Tanaka S, Kim S, Shioi A, Okuno Y, Raines EW, Iwao H, Otani S, Nishizawa Y.

Circ Res. 2001 Mar 16;88(5):460-7.


Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury.

Shi Y, Fard A, Galeo A, Hutchinson HG, Vermani P, Dodge GR, Hall DJ, Shaheen F, Zalewski A.

Circulation. 1994 Aug;90(2):944-51.


Neuron-derived orphan receptor-1 (NOR-1) modulates vascular smooth muscle cell proliferation.

Martínez-González J, Rius J, Castelló A, Cases-Langhoff C, Badimon L.

Circ Res. 2003 Jan 10;92(1):96-103.


Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapy.

Lompré AM, Hadri L, Merlet E, Keuylian Z, Mougenot N, Karakikes I, Chen J, Atassi F, Marchand A, Blaise R, Limon I, McPhee SW, Samulski RJ, Hajjar RJ, Lipskaia L.

Gene Ther. 2013 Sep;20(9):901-12. doi: 10.1038/gt.2013.13. Epub 2013 Mar 28.


[Effect of antisense oligonucleotides on myo-intimal hyperplasia in a model of abdominal aortic injury in the rat].

Chemla E, Julia P, Nierat J, Eudes D, Bruneval P, Carpentier A, Fabiani JN.

Arch Mal Coeur Vaiss. 1995 Mar;88(3):381-9. French.


Serum response factor regulates expression of phosphatase and tensin homolog through a microRNA network in vascular smooth muscle cells.

Horita HN, Simpson PA, Ostriker A, Furgeson S, Van Putten V, Weiser-Evans MC, Nemenoff RA.

Arterioscler Thromb Vasc Biol. 2011 Dec;31(12):2909-19. doi: 10.1161/ATVBAHA.111.233585. Epub 2011 Sep 22.


Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.

Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ.

Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8474-8.


Flank sequences of miR-145/143 and their aberrant expression in vascular disease: mechanism and therapeutic application.

Liu X, Cheng Y, Yang J, Qin S, Chen X, Tang X, Zhou X, Krall TJ, Zhang C.

J Am Heart Assoc. 2013 Oct 28;2(6):e000407. doi: 10.1161/JAHA.113.000407.

Supplemental Content

Support Center